aamc.org does not support this web browser.
  • Washington Highlights

    DEA Issues Guidance on MATE Act’s Training Required on Opioid Use Disorder

    Ki Stewart, Senior Policy and Regulatory Analyst
    For Media Inquiries

    On Mar. 28, the U.S. Drug Enforcement Administration (DEA) issued guidance outlining requirements for a one-time, eight-hour training “on the treatment and management of patients with opioid or other substance use disorders.” The Medication Access and Training Expansion (MATE) Act that was passed as part of the Consolidated Appropriations Act (CAA) of 2023 (P.L. 117-328) requires all DEA-registered providers to complete this training.  

    The deadline to satisfy this training requirement is the date of a practitioner’s next scheduled DEA registration submission beginning June 27. Practitioners will be required to check a box on their online DEA registration form to affirm that they have completed the training, regardless of whether the practitioner is a first-time applicant or is renewing their registration.  

    Practitioners have satisfied the MATE training requirement if they “are board certified in addiction medicine or addiction psychiatry from the American Board of Medical Specialties, the American Board of Addiction Medicine, or the American Osteopathic Association” or if they “graduated in good standing from a medical (allopathic or osteopathic), dental, physician assistant, or advanced practice nursing school in the United States within five years of June 27, 2023, and successfully completed a comprehensive curriculum that included at least eight hours of training” on opioid or other substance use disorders. Practitioners may also complete the training requirement through any of the accredited medical associations or organizations listed by the guidance.